Latest News about VSAR
Recent news which mentions VSAR
The Daily Biotech Pulse: FDA Thumbs Down For Trevena, Corium To Go Private, Immune Design Discontinues Cancer Vaccine Program
October 12, 2018
From Benzinga
21 Stocks Moving In Monday's Pre-Market Session
June 11, 2018
From Benzinga
Stocks to Watch Next Week
June 09, 2018
From AC Investor Blog
A few trade ideas for next week
May 06, 2018
From AC Investor Blog
42 Biggest Movers From Yesterday
December 06, 2017
From Benzinga
30 Stocks Moving In Wednesday's Mid-Day Session
December 06, 2017
From Benzinga
28 Stocks Moving In Wednesday's Pre-Market Session
December 06, 2017
From Benzinga
Stocks on my Watchlist for Next Week
December 03, 2017
From AC Investor Blog
50 Biggest Movers From Friday
October 29, 2017
From Benzinga
45 Stocks Moving In Friday's Mid-Day Session
October 27, 2017
From Benzinga
32 Stocks Moving In Friday's Pre-Market Session
October 27, 2017
From Benzinga
31 Stocks Moving In Wednesday's Pre-Market Session
October 25, 2017
From Benzinga
Life (Science) Lessons: The Hows And Whos To Play Biotech
October 06, 2017
From Benzinga
18 Stocks Moving In Tuesday's Pre-Market Session
October 03, 2017
From Benzinga
20 Biggest Mid-Day Losers For Wednesday
September 27, 2017
From Benzinga
25 Stocks Moving In Wednesday's Pre-Market Session
September 27, 2017
From Benzinga
20 Stocks Moving In Monday's Pre-Market Session
September 25, 2017
From Benzinga
Why Versartis, Wayfair, and Compass Minerals Slumped Today
September 22, 2017
From Motley Fool
From Motley Fool
12 Biggest Mid-Day Losers For Friday
September 22, 2017
From Benzinga
5 Biggest Price Target Changes For Friday
September 22, 2017
From Benzinga
Mid-Day Market Update: Revolution Lighting Technologies Drops Following Reduced FY2017 Outlook; Ascendis Pharma Shares Surge
September 22, 2017
From Benzinga
What Do Versartis' Troubles Mean For Opko Health?
September 22, 2017
From Benzinga
Mid-Morning Market Update: Markets Edge Lower; CarMax Tops Q2 Expectations
September 22, 2017
From Benzinga
Benzinga's Top Upgrades, Downgrades For September 22, 2017
September 22, 2017
From Benzinga
Ascendis Pharma shares surge 42% as competitor Versartis plummets 85% on failed trial
September 22, 2017
From MarketWatch
Versartis' Somavaratan Still Has A Path Forward; Cantor Reiterates Buy
September 22, 2017
From Benzinga
20 Stocks Moving In Friday's Pre-Market Session
September 22, 2017
From Benzinga
Overly complacent investors may be in for a rude Fed wake-up call
September 22, 2017
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.